The Wistar Institute.
The Wistar Institute;
J Vis Exp. 2021 Sep 27(175). doi: 10.3791/62906.
Animal models provide a vital translation between in vitro and in vivo biomedical research. Humanized mouse models provide a bridge in the representation of human systems, thereby allowing for a more accurate study of pathogenesis, biomarkers, and many other scientific queries. In this method described, immune-deficient NOD-scid IL2Rγnull (NSG) mice are implanted with autologous thymus, injected with liver-derived CD34 cells followed by a series of injected cytokine deliveries. In contrast to other models of a similar nature, the model described here promotes an improved reconstitution of immune cells by delivering cytokines and growth factors via transgenes encoded in AAV8 or pMV101 DNA-based vectors. Moreover, it offers long-term stability with reconstituted mice having an average lifespan of 30 weeks after CD34 injections. Through this model, we hope to provide a stable and impactful method of studying immunotherapy and human disease in a murine model, thus demonstrating the need for predictive preclinical models.
动物模型在体外和体内生物医学研究之间提供了重要的转化。人源化小鼠模型在代表人类系统方面提供了桥梁,从而能够更准确地研究发病机制、生物标志物和许多其他科学问题。在描述的这种方法中,免疫缺陷型 NOD-scid IL2Rγnull(NSG)小鼠被植入自体胸腺,注射肝来源的 CD34 细胞,然后进行一系列细胞因子注射。与其他类似性质的模型相比,这里描述的模型通过使用腺相关病毒 8 或 pMV101 DNA 载体中编码的转基因来输送细胞因子和生长因子,促进了免疫细胞的更好重建。此外,该模型具有长期稳定性,在 CD34 注射后,重建的小鼠的平均寿命为 30 周。通过该模型,我们希望提供一种稳定且有影响力的方法来研究免疫疗法和人类疾病在小鼠模型中的作用,从而证明需要预测性临床前模型。